Popular Articles

Surveys Show GPs Need More Support - Australian Medical Association
A study which found up to one third of GPs are planning to retire early highlights the need for governments to boost support for general practice, AMA Federal President, Dr Andrew Pesce, said today.
pharmacy online
Plexxikon Announces PLX4032 Phase 1 Data Showing Objective Responses In Metastatic Melanoma Patients
Plexxikon Inc. today announced preliminary data from a Phase 1 clinical study investigating PLX4032 (R7204). PLX4032 is a novel, oral and highly selective drug that targets the BRAFV600E cancer-causing mutation that occurs in most melanomas and about eight percent of all solid tumors. In patients whose cancer harbors this mutation and who were treated with therapeutic doses of PLX4032, tumor shrinkage and extended progression-free survival have been observed. Currently, two extension studies are being conducted in mutation-positive melanoma and colorectal cancer patients. Following the initial positive findings announced today, larger clinical trials to support a registration program for product approval are targeted to start later in 2009. Plexxikon and Roche are co-developing PLX4032 under their 2006 license and collaboration agreement.
News of the day
New Report Finds Obesity Epidemic Increases, Mississippi Weighs In As Heaviest State
Adult obesity rates increased in 23 states and did not decrease in a single state in the past year, according to F as in Fat: How Obesity Policies Are Failing in America 2009, a report released today by the Trust for America"s Health (TFAH) and the Robert Wood Johnson Foundation (RWJF). In addition, the percentage of obese or overweight children is at or above 30 percent in 30 states.
Diagnostics

Removal Of Tonsils And Adenoids Associated With Ongoing Benefits For Children With Breathing Problems During Sleep

Two and a half years after children with sleep-related breathing disorders had surgery to remove their tonsils and adenoids (glands in the back of the throat), they appear to sleep better than they did before the procedure but not as well as they did six months after, according to a report in the July issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals. Initial improvements in their behavior were maintained except when measured by an index of attention-deficit/hyperactivity disorder (ADHD) symptoms. "Since the publication of our previous report demonstrating improvements in both sleep and behavior at six months after adenotonsillectomy for children with sleep-disordered breathing, there have been several articles that continue to support the impact of sleep-disordered breathing on neurocognitive development, behavior and quality of life," the authors write as background information in the article. "Specifically, ADHD, hyperactivity and behavior have been shown to improve at six or 12 months after adenotonsillectomy in correlation with improved postoperative polysomnography [sleep monitoring] parameters regardless of which instruments were used to evaluate behavior." Julie L. Wei, M.D., of the University of Kansas School of Medicine, Kansas City, and colleagues analyzed long-term (2.4 to 3.6 years) follow-up data from 44 of 71 children with sleep-disordered breathing who initially participated in the six-month study. Before surgery, six months afterward and again at least two years afterward, parents completed a questionnaire assessing their child"s sleep and a multi-part parent rating scale with sections about ADHD symptoms, cognitive problems or inattention, hyperactivity and oppositional behavior. "Our longitudinal study demonstrates that improvements in sleep and behavior may not be exactly maintained over time, but at 2.5 years after the surgical intervention, all parameters reported in this study except the ADHD index remained below baseline values," the authors write. "Although speculative and based on extrapolation, this longitudinal model shows that even if the sleep-related breathing disorder subscale scores increase by 7 percent per year for many consecutive years, which is a statistically significant increase compared with baseline values, it would take nine or 10 years before the values could climb back to baseline values, if indeed a return to baseline values were likely." Because it is not a randomized controlled trial, the results do not prove the relationship between adenotonsillectomy and changes in sleep and behavior. However, the findings do support an association between the intervention and improvements in theses outcomes, the authors note. Arch Otolaryngol Head Neck Surg. 2009;135[7]:642-646. Archives of Otolaryngology-Head & Neck Surgery


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):